Rhodiola algida
Rhodiola algida · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Rhodiola algida is a resilient perennial herb found primarily in the harsh, high-altitude environments of the Arctic and subarctic regions. This plant has long been noted for its ability to thrive under extreme climatic stress, making it a subject of botanical interest. Recent scientific investigations have focused on isolating its bioactive fraction to better understand its unique chemical properties. By concentrating these specific compounds, researchers aim to unlock the therapeutic potential hidden within its cellular structure. Such preparations provide a foundation for exploring how this hardy species might influence human physiological resilience.
- Synonyms
- Chamaerhodiola Euphorbioides · Chamaerhodiola Algida · 5 more
- Common names
- Not available
- Family
- Crassulaceae
- Distribution
- Northern America
- Plant Parts
- Not available
Classification
Synonyms
Rhodiola algida is a botanical subject characterized by a complex web of taxonomic synonyms. Throughout various classifications, this species has been identified under names such as Chamaerhodiola algida and Chamaerhodiola euphorbioides. It is also frequently referred to in older or alternative literature as Sedum algidum. Further distinctions in botanical studies include its categorization as Sedum algidum var. altaicum and Sedum algidum var. euphorbioides. Understanding these various naming conventions is essential for accurate identification and scientific consistency.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Rhodiola algida belongs to the vast kingdom Plantae, representing a specialized branch of the natural world. Within this expansive group, it is classified under the class Equisetopsida and the order Saxifragales. This botanical specimen is further defined by its membership in the genus Rhodiola. Finally, it finds its specific familial home within the Crassulaceae family. Through these scientific classifications, the unique biological identity of the plant is clearly established.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Saxifragales |
| Family | Crassulaceae |
| Genus | Rhodiola |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Rhodiola algida is a resilient species primarily distributed throughout the Asia-Temperate region. Its natural range extends across the vast landscapes of Central Asia, with significant populations found in Kazakhstan. The plant also thrives within the borders of Mongolia, showcasing its ability to adapt to diverse environments. Furthermore, it is widely scattered across various parts of Siberia, including the Altay and Tuva regions. Specific sightings have also been recorded in the Krasnoyarsk area, highlighting its widespread presence in these northern territories.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Rhodiola algida is characterized by its distinctive growth form as a small herb. This species typically reaches a modest height, generally staying well below 0.25 meters. In most environments, its stature fluctuates between a minimum of 0.06 meters and its maximum possible height.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Conditions
Rhodiola algida is a plant traditionally used to prevent and treat acute mountain sickness. This herb is specifically recognized for its anti-hypoxic properties when used in high-altitude environments. In scientific studies, it serves as a positive control to evaluate the efficacy of other plateau herbs against hypoxia. By comparing its effects to new extracts, researchers can measure how well a substance mitigates altitude-related distress. Therefore, Rhodiola algida remains a key botanical reference for managing the physiological challenges of high altitudes.
Preparations
Rhodiola algida is prepared as a bioactive fraction known as ACRT to investigate its therapeutic potential. This specific fraction was utilized in a study to evaluate its effects on chronic hypoxia-induced pulmonary arterial hypertension in rats. Researchers analyzed the pharmacodynamic actions of this bioactive fraction to understand its underlying mechanisms. Through chemical profiling, 38 distinct constituents were identified within the prepared ACRT fraction. Ultimately, the study demonstrated that this bioactive fraction helps alleviate pulmonary hypertension by inhibiting cell proliferation.